IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomes

Rui Sun,Matija Hedl,Clara Abraham

DOI: https://doi.org/10.1136/gutjnl-2018-316830

IF: 24.5

2019-05-16

Gut

Abstract:Objective The interleukin (IL)23 pathway contributes to IBD pathogenesis and is being actively studied as a therapeutic target in patients with IBD. Unexpected outcomes in these therapeutic trials have highlighted the importance of understanding the cell types and mechanisms through which IL23 regulates immune outcomes. How IL23 regulates macrophage outcomes and the consequences of the IL23R R381Q IBD-protective variant on macrophages are not well defined; macrophages are key players in IBD pathogenesis and inflammation. Design We analysed protein and RNA expression, signalling and localisation in human monocyte-derived macrophages (MDMs) through western blot, ELISA, real-time PCR, flow cytometry, immunoprecipitation and microscopy. Results IL23R was critical for optimal levels of pattern-recognition receptor (PRR)-induced signalling and cytokines in human MDMs. In contrast to the coreceptor IL12Rβ1, IL23 induced dynamic IL23R cell surface regulation and this required clathrin and dynamin-mediated endocytosis and endocytic recycling-dependent pathways; these pathways were essential for IL23R-mediated outcomes. The IBD-protective IL23R R381Q variant showed distinct outcomes. Relative to IL23R R381, HeLa cells expressing IL23R Q381 showed decreased IL23R recycling and reduced assembly of IL23R Q381 with Janus kinase/signal transducer and activator of transcription pathway members. In MDMs from IL23R Q381 carriers, IL23R accumulated in late endosomes and lysosomes on IL23 treatment and cells demonstrated decreased IL23R- and PRR-induced signalling and cytokines relative to IL23R R381 MDMs. Conclusion Macrophage-mediated inflammatory pathways are key contributors to IBD pathogenesis, and we identify an autocrine/paracrine IL23 requirement in PRR-initiated human macrophage outcomes and in human intestinal myeloid cells, establish that IL23R undergoes ligand-induced recycling, define mechanisms regulating IL23R-induced signalling and determine how the IBD-protective IL23R R381Q variant modulates these processes.

gastroenterology & hepatology

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the following aspects: 1. **The role of IL23 in human macrophages**: - Investigate how IL23 regulates the signal transduction and cytokine secretion of human monocyte - derived macrophages (MDMs) under the stimulation of microbial products. - Explore whether IL23 significantly amplifies the pattern recognition receptor (PRR) - induced signal transduction and cytokine secretion through the autocrine/paracrine pathway. 2. **The signal transduction mechanism of IL23R**: - Identify the members of the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway activated by IL23R, and the roles of these pathways in MDMs. - Explore the dynamic regulation mechanism of the cell surface of IL23R, especially the role of endocytosis - and recycling - dependent pathways in it. 3. **The impact of the IBD - protective IL23R R381Q variant**: - Study how the IBD - protective IL23R R381Q variant regulates IL23R - mediated signal transduction and cytokine secretion. - Analyze the specific impacts of the IL23R R381Q variant on IL23R cell - surface expression, signal complex recruitment, and cytokine secretion. Specifically, the paper uses the following experimental and analytical methods to solve these problems: - **Determination of cytokine secretion**: By treating MDMs and detecting the cytokine secretion, evaluate the role of IL23 in the PRR - induced inflammatory response. - **Analysis of signal pathways**: Use Western blot, flow cytometry, immunoprecipitation, and microscopy techniques to study the JAK/STAT, MAPK, and NFκB pathways activated by IL23R. - **Dynamic regulation of IL23R**: Through siRNA knockdown, inhibitor treatment, and confocal microscopy observation, explore the endocytosis and recycling mechanisms of IL23R. - **Functional study of the IBD - protective variant**: By over - expressing IL23R R381 and Q381 variants, compare their differences in signal transduction and cytokine secretion. These research results contribute to a better understanding of the role of the IL23/IL23R pathway in inflammatory bowel disease (IBD), providing new insights and potential targets for future clinical treatment.

IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomes

Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance

Inflammatory Disease Protective R381q Il23 Receptor Polymorphism Results In Decreased Primary Cd4+And Cd8+Human T-Cell Functional Responses

Inducible Microrna-223 Down-Regulation Promotes Tlr-Triggered Il-6 And Il-1 Beta Production In Macrophages By Targeting Stat3

IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis

CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation

The IL-21/IL-21R signaling axis regulates CD4+ T cell responsiveness to IL-12 to promote bacterial-induced colitis

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology

DOP89 Unfolded protein response controls group 3 innate lymphoid cells in IBD

IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells

Leukocyte immunoglobulin-like receptor A3 is increased in IBD patients and functions as an anti-inflammatory modulator

The Dichotomous Pattern of IL-12R and IL-23R Expression Elucidates the Role of IL-12 and IL-23 in Inflammation

Interleukin-35 -Producing B Cells Rescues Inflammatory Bowel Disease in a Mouse Model Via STAT3 Phosphorylation and Intestinal Microbiota Modification

GROUP 3 INNATE LYMPHOID CELLS RELY ON ER STRESS RESPONSE FOR CYTOKINE PRODUCTION IN IBD

Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling

OP28 Defective STAT3 signaling in refractory Very Early Onset Inflammatory Bowel Disease is associated with a transcriptional signature which predicts response to anti-IL23-based therapies

The Pathogenic Roles of IL-22 in Colitis: Its Transcription Regulation by Musculin in T Helper Subsets and Innate Lymphoid Cells

Recombinant Tumor Necrosis Factor Alpha (TNF alpha) Peptide-Based Vaccine Ameliorates Acute and Chronic Murine Colitis

IL-10 Engages Macrophages to Shift Th17 Cytokine Dependency and Pathogenicity During T Cell-Mediated Colitis (MUC8P.729)

The IRE1α/XBP1 pathway sustains cytokine responses of group 3 innate lymphoid cells in inflammatory bowel disease

The Expression of Interleukin-23 Receptor and Interleukin-17a in Patients with Inflammatory Bowel Disease and its Clinical Significance